(Q44026686)

29 November 2017

Troglitazone enhances the hepatotoxicity of acetaminophen by inducing CYP3A in rats (English)

1 reference

29 November 2017

1 reference

1 reference

Jue Li

1

1 reference

29 November 2017

Takashi Kaneko

2

1 reference

29 November 2017

Yuan Wang

3

1 reference

29 November 2017

Li-Qiang Qin

4

1 reference

29 November 2017

Pei-Yu Wang

5

1 reference

29 November 2017

Akio Sato

6

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

29 November 2017

10

1 reference

inferred from page(s)

published in

Toxicology

1 reference

29 November 2017

176

1 reference

29 November 2017

1-2

1 reference

29 November 2017

91-100

1 reference

Zonation of acetaminophen metabolism and cytochrome P450 2E1-mediated toxicity studied in isolated periportal and perivenous hepatocytes

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Late-onset troglitazone-induced hepatic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

In vitro studies on the action of CS-045, a new antidiabetic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Tissue sulfhydryl groups

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Subacute hepatic failure associated with a new antidiabetic agent, troglitazone: a case report with autopsy examination

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Severe hepatotoxicity associated with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

A novel antidiabetic drug, troglitazone--reason for hope and concern

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Metabolic effects of troglitazone on fat-induced insulin resistance in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Role of ethanol-inducible cytochrome P-450 IIE1 in carbon tetrachloride-induced damage to centrilobular hepatocytes from ethanol-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Troglitazone-associated hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Troglitazone-induced fulminant hepatic failure. Acute Liver Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Molecular mechanisms of the hepatotoxicity caused by acetaminophen

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Troglitazone-induced hepatic failure leading to liver transplantation. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Paracetamol Overdosage Pharmacological Considerations and Clinical Management

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Improved high-performance liquid chromatographic procedure for the separation and quantification of hydroxytestosterone metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Effect of troglitazone on cytochrome P450 enzymes in primary cultures of human and rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Acetaminophen and its toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Acetaminophen toxicity in an urban county hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

An autopsy case of troglitazone-induced fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Necrogenic Action of Carbon Tetrachloride in the Rat: A Speculative Mechanism Based on Activation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Loss of CYP2E1 and CYP1A2 activity as a function of acetaminophen dose: relation to toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Paracetamol (acetaminophen) poisoning

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Fatal hepatotoxicity associated with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Acarbose alone or in combination with ethanol potentiates the hepatotoxicity of carbon tetrachloride and acetaminophen in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Role of cytochromes P450 in drug metabolism and hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

Hepatic dysfunction associated with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2802%2900143-9

7 January 2021

10.1016/S0300-483X(02)00143-9

Identifiers

DOI

1 reference

29 November 2017

1 reference